MU
Michael Ulz Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Karyopharm Therapeutics
KPTI
$57.2M
| $6.60 | $25 |
279%
upside
| Outperform |
12 Aug ‘25
27 days ago |
|
2
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $405 |
10%
downside
| Equal-Weight |
1 Aug ‘25
1 month ago |
|
3
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $62 |
1%
upside
| Overweight |
31 Jul ‘25
1 month ago |
|
|
SLN
4
Silence Therapeutics
SLN
$269M
| $5.69 | $25 |
339%
upside
| Overweight |
9 May ‘25
4 months ago |
|
5
Viking Therapeutics
VKTX
$3.03B
| $26.98 | $102 |
278%
upside
| Overweight |
24 Apr ‘25
4 months ago |
|
6
Kyverna Therapeutics
KYTX
$170M
| $3.94 | $20 |
408%
upside
| Overweight |
1 Apr ‘25
5 months ago |
|
7
Cabaletta Bio
CABA
$155M
| $1.70 | $22 |
1,194%
upside
| Overweight |
1 Apr ‘25
5 months ago |
|
|
AARD
8
Aardvark Therapeutics, Inc. Common Stock
AARD
$187M
| $8.60 | $29 |
237%
upside
| Overweight |
10 Mar ‘25
6 months ago |
|
9
Y-mAbs Therapeutics
YMAB
$390M
| $8.58 | $7 |
18%
downside
| Underweight |
5 Mar ‘25
6 months ago |
|
10
Iovance Biotherapeutics
IOVA
$901M
| $2.49 | $20 |
703%
upside
| Outperform |
28 Feb ‘25
6 months ago |
|
11
Fractyl Health
GUTS
$65.4M
| $0.9228 | $10 |
984%
upside
| Overweight |
3 Feb ‘25
7 months ago |
|
12
Akero Therapeutics
AKRO
$3.58B
| $44.72 | $96 |
115%
upside
| Overweight |
28 Jan ‘25
7 months ago |
|
13
Dyne Therapeutics
DYN
$2.02B
| $14.22 | $52 |
266%
upside
| Overweight |
14 Aug ‘24
1 year ago |
|
14
Mirum Pharmaceuticals
MIRM
$3.82B
| $76.06 | $57 |
25%
downside
| Overweight |
18 Jun ‘24
1 year ago |
|
15
Arrowhead Research
ARWR
$4.02B
| $29.07 | $27 |
7%
downside
| Equal-Weight |
13 May ‘24
1 year ago |
|
16
Fate Therapeutics
FATE
$116M
| $1.01 | $7 |
593%
upside
| Equal-Weight |
27 Feb ‘24
1 year ago |
|
|
KLRS
17
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $4.62 | $11.50 |
149%
upside
| Underweight |
5 Jan ‘24
1 year ago |
|
18
Oric Pharmaceuticals
ORIC
$1.06B
| $10.88 | $27 |
148%
upside
| Outperform |
16 Aug ‘23
2 years ago |
|
|
19
Karyopharm Therapeutics
KPTI
$57.2M
| $6.60 | $60 |
809%
upside
| Equal-Weight |
7 Aug ‘23
2 years ago |
|
20
Senti Biosciences
SNTI
$36.4M
| $1.39 | $20 |
1,339%
upside
| Equal-Weight |
24 Mar ‘23
2 years ago |
|
21
Rocket Pharmaceuticals
RCKT
$354M
| $3.28 | $45 |
1,272%
upside
| Overweight |
1 Feb ‘23
2 years ago |
|
22
Xilio Therapeutics
XLO
$36.3M
| $0.6998 | $10 |
1,329%
upside
| Overweight |
27 Jan ‘23
2 years ago |
|
23
Taysha Gene Therapies
TSHA
$917M
| $3.36 | $3 |
11%
downside
| Equal-Weight |
27 Jan ‘23
2 years ago |
|
24
Vir Biotechnology
VIR
$732M
| $5.27 | $30 |
469%
upside
| Equal-Weight |
27 Jan ‘23
2 years ago |
|
|
TECX
25
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $16.80 | $36 |
114%
upside
| Equal-Weight |
5 Jan ‘22
3 years ago |
|